Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Platelet-rich plasma shows promise for treating various female reproductive health issues but requires more research.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

Clascoterone 1% cream is a promising new treatment for acne.

5α-reductases increase epitestosterone's effect on androgen receptors.

Hair loss is a common side effect of hormone treatments for cancer.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Clascoterone cream could be used for other skin conditions affected by hormones.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Treating prolactinoma doesn't significantly affect hirsutism or cause high androgen levels.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.